Heidelberg University
Clinical trials sponsored by Heidelberg University, explained in plain language.
-
Heart drug test for deadly lung pressure disease halted
Disease control TerminatedThis study aimed to see if the drug riociguat could improve the size and function of the right side of the heart in people with two severe types of lung blood pressure disease. It involved 30 adults who were either new to treatment or switching from certain other medications. The…
Phase: PHASE4 • Sponsor: Heidelberg University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Early intervention trial for lung blood vessel disease halted
Disease control TerminatedThis study aimed to see if a drug called riociguat could help control early-stage pulmonary vascular disease, a condition that can lead to high blood pressure in the lungs. It involved 35 adults with connective tissue diseases like systemic sclerosis who showed early signs of the…
Phase: PHASE2 • Sponsor: Heidelberg University • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC